Stopping a GLP-1 medication does not directly cause muscle loss, but appetite often returns, which can lead to weight regain if resistance training and higher protein habits built during the medication period are not maintained
Why this wo Why This Cluster Matters for Appetite, Metabolism & Long-Term Weight Stability GLP-1 is a powerful metabolic hormone but it does not operate in isolation
Serious Risks: Prescribing information for GLP-1 medications includes boxed warnings about: Adherence Factors: According to experts quoted in coverage of the FDA approval, real-world adherence may differ from clinical trial conditions
Better Health From The Inside Out At Relive Health in Austin, we take the time to understand whats really behind your health issues so we can help you address them at their source
Tirzepatide is a new class of medication that can offer eligible people living with obesity another treatment option and potentially reduce the economic impact of obesity, which is estimated to cost the NHS 6.1 billion annually. This authorisation is based on results from the phase 3 SURMOUNT-1 and SURMOUNT-2 clinical trials, which both met their co-primary endpoints of demonstrating that tirzepatide 10mg and 15mg achieved superior mean percent change in body weight from baseline and greater percentage of participants achieving body weight reductions of at least 5% compared to placebo
